AN EYEDROP FOR CATARACT?


According to this press release:
"AlphaRX, an emerging biopharmaceutical company ...is pleased to announce that the development of the formulation for Acusolin™, ...has been completed and in vivo studies are underway as scheduled.

"The Company will investigate Acusolin™ using an established cataract animal model. This model is designed to demonstrate Acusolin™'s ability to prevent and treat senile cataracts."
I'll believe it when I see it.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH